Sustained benefits of autologous serum eye drops on self-reported ocular symptoms and vision-related quality of life in Australian patients with dry eye and corneal epithelial defects.
This research examined the effect of autologous serum eye drops (ASED) on ocular symptoms, visual-related functioning and quality of life for patients failing other therapies. Patients (N = 77) were asked to complete a survey prior to ASED use, and 2 and 12 months post-treatment. Significant improvements in symptom frequency and severity were documented for dryness, ocular pain and grittiness at 2 and 12 months. Patients felt more in control and required less help from others at 12 months. ASED produce sustained benefits to dry eye symptoms, improve feelings of control and reduce requirements for assistance from others.